Name: Young-Onset GI Cancer (en Inglés)
SKU: 57730919
Price: 67.25 USD
Availability: InStock
Author: Aharon, Irit Ben ; Barreto, Savio George
ISBN: 9783036579641

portada Young-Onset GI Cancer (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Aharon, Irit Ben ; Barreto, Savio George

Idioma

Inglés

N° páginas

134

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1.3 cm

Peso

0.49 kg.

ISBN13

9783036579641

Categorías

Industria y estudios industriales
Sistemas y servicios de salud
Farmacología
Biología, ciencias de la vida

Young-Onset GI Cancer (en Inglés)

Aharon, Irit Ben ; Barreto, Savio George (Autor) · Mdpi AG · Tapa Dura

Libro Nuevo Importado

Envío: 21 a 28 días háb.

$ 122.28$ 67.25

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 67.25

Llega entre el 29 Oct y el 13 Nov a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Young-Onset GI Cancer (en Inglés)"

In the last decade, the incidence of cancer in young patients has increased in several cancer types according to the US Surveillance, Epidemiology and End Result (SEER) data and other worldwide registries. Recently, Sung and colleagues published an extensive pooled analysis from the US in Lancet Public Health, which revealed a dramatic increase in cancer incidence among younger adults (aged 25-49 years), mainly in "obesity-related" cancers, most of which occur in the gastrointestinal (GI) tract. Several studies over the past decade have indicated a significant increase in colorectal cancer incidence among young adults below the age of 50 years. Current evidence suggests that the majority of early-onset GI cancers are sporadic and harbor no familial etiology, indicating the potentially significant role of environmental and behavioral factors in their pathogenesis. Furthermore, the gut microbiome has been proposed to play a key role in CRC carcinogenesis. The scope of this Special Issue of Cancers is to highlight perspectives regarding biology, etiology, late-term toxicities and quality of life which are unique and relevant to young-onset GI cancer cases.